Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The polycystic ovary syndrome is a common cause of infertility. Clomiphene and insulin sensitizers are used alone and in combination to induce ovulation, but it is unknown whether one approach is superior. METHODS: We randomly assigned 626 infertile women with the polycystic ovary syndrome to receive clomiphene citrate plus placebo, extended-release metformin plus placebo, or a combination of metformin and clomiphene for up to 6 months. Medication was discontinued when pregnancy was confirmed, and subjects were followed until delivery. RESULTS: The live-birth rate was 22.5% (47 of 209 subjects) in the clomiphene group, 7.2% (15 of 208) in the metformin group, and 26.8% (56 of 209) in the combination-therapy group (P<0.001 for metformin vs. both clomiphene and combination therapy; P=0.31 for clomiphene vs. combination therapy). Among pregnancies, the rate of multiple pregnancy was 6.0% in the clomiphene group, 0% in the metformin group, and 3.1% in the combination-therapy group. The rates of first-trimester pregnancy loss did not differ significantly among the groups. However, the conception rate among subjects who ovulated was significantly lower in the metformin group (21.7%) than in either the clomiphene group (39.5%, P=0.002) or the combination-therapy group (46.0%, P<0.001). With the exception of pregnancy complications, adverse-event rates were similar in all groups, though gastrointestinal side effects were more frequent, and vasomotor and ovulatory symptoms less frequent, in the metformin group than in the clomiphene group. CONCLUSIONS: Clomiphene is superior to metformin in achieving live birth in infertile women with the polycystic ovary syndrome, although multiple birth is a complication. (ClinicalTrials.gov number, NCT00068861 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and there is no evidence-based need to continue metformin in these individuals (92)(93)(94).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [92]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These findings are consistent with previous systematic reviews comparing metformin to placebo with or without lifestyle.61,64,65”
From The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials (2023) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
RetractedThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,881
Maternal Morbid Obesity and the Risk of Adverse Pregnancy Outcome
Cedergren, M. I. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000107291.46159.00 · Cited by 1,248
Obesity, obstetric complications and cesarean delivery rate–a population-based screening study
Weiss, J. L., Malone, F. D., Emig, D., Ball, R. H., Nyberg, D. A., Comstock, C. H., Saade, G., Eddleman, K., Carter, S. M., Craigo, S. D., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.09.058 · Cited by 1,138
Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia
ACOG Committee on Obstetric Practice (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01747-1 · Cited by 1,058
A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome
Boomsma, C. M., Eijkemans, M. J. C., Hughes, E. G., Visser, G. H. A., Fauser, B. C. J. M., & Macklon, N. S. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml036 · Cited by 852
Metformin in polycystic ovary syndrome: systematic review and meta-analysis
Lord, J. M., Flight, I. H. K., & Norman, R. J. (2003) · BMJ · doi:10.1136/bmj.327.7421.951 · Cited by 786
Nestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 784
Self-citationCharacterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D., & Allan, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401703 · Cited by 518
Self-citationProfound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
Dunaif, A. E., Segal, K. R., Futterweit, W., et al. (1989) · Diabetes · doi:10.2337/diabetes.38.9.1165 · Cited by 518
Azziz, R., Ehrmann, D., Legro, R. S., Whitcomb, R. W., Hanley, R., Fereshetian, A. G., O’Keefe, M., & Ghazzi, M. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7375 · Cited by 517
Self-citationEffects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., Roberts, K. A., & Nestler, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8207 · Cited by 492
Self-citationHomburg, R., Armar, N. A., Eshel, A., Adams, J., & Jacobs, H. S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1024 · Cited by 436
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies
Hull, M. G. R. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709023610 · Cited by 427
Azziz, R. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1626 · Cited by 376
Vandermolen, D. T., Ratts, V. S., Evans, W. S., Stovall, D. W., Kauma, S. W., & Nestler, J. E. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01675-7 · Cited by 356
Self-citationMoll, E., Bossuyt, P. M. M., Korevaar, J. C., Lambalk, C. B., & van der Veen, F. (2006) · BMJ · doi:10.1136/bmj.38867.631551.55 · Cited by 299
Palomba, S., Orio, F., Falbo, A., Manguso, F., Russo, T., Cascella, T., Tolino, A., Carmina, E., Colao, A., & Zullo, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0110 · Cited by 279
Kocak, M., Caliskan, E., Simsir, C., & Haberal, A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02941-7 · Cited by 268
Body Mass Index and Delayed Conception: A European Multicenter Study on Infertility and Subfecundity
Bolumar, F., Olsen, J., Rebagliato, M., Saez-Lloret, I., Bisanti, L., & the European Study Group on Infertility and Subfecundity (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010150 · Cited by 179
Palomba, S., Orio, F., Nardo, L. G., Falbo, A., Russo, T., Corea, D., Doldo, P., Lombardi, G., Tolino, A., Colao, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0689 · Cited by 177
Schwartz, S., Fonseca, V., Berner, B., Cramer, M., Chiang, Y.-K., & Lewin, A. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1967 · Cited by 128
Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., McGovern, P. G., Cataldo, N. A., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.037 · Cited by 122
Self-citationEffects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.524 · Cited by 120
Pharmacokinetics of Metformin Gastric‐Retentive Tablets in Healthy Volunteers
Gusler, G., Gorsline, J., Levy, G., Zhang, S. Z., Weston, I. E., Naret, D., & Berner, B. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010546 · Cited by 90
Fujioka, K., Brazg, R. L., Raz, I., Bruce, S., Joyal, S., Swanink, R., & Pans, M. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00369.x · Cited by 73
Should we continue or stop insulin sensitizing drugs during pregnancy?
Norman, R. J., Wang, J. X., & Hague, W. (2004) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-200406000-00007 · Cited by 71
Şahin, Y., Yirmibeş, Ü., Keleştimur, F., & Aygen, E. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.09.036 · Cited by 71
Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
Legro, R. S. (2004) · Human Reproduction · doi:10.1093/humrep/deh322 · Cited by 42
Self-citationMyers, E. R., Silva, S. G., Hafley, G. E., Kunselman, A. R., Nestler, J. E., & Legro, R. S. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.01.006 · Cited by 23
Self-citationUtility of screening for other causes of infertility in women with “known” polycystic ovary syndrome
McGovern, P. G., Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., Steinkampf, M. P., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.06.050 · Cited by 20
Self-citationJOHNSON, N. P. (2006) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2006.00544.x · Cited by 17
Takahashi, K., Uchida, A., Yamasaki, H., Ozaki, T., & Kitao, M. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56814-9 · Cited by 14
Research works printed but not linked: 4
- Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992:377-84. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Re- vised 2003 consensus on diagnostic crite- ria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
- 2004, Fertil Steril, 81, 19
- The New England Journal of Medicine Downloaded from nejm.org on August 29, 2023. For personal use only. No other uses without permission. Copyright © 2007 Massachusetts Medical Society. All rights reserved. n engl j med 356;
- www.nejm.org february 8, 2007 566 Clomiphene versus Metformin in the Polycystic Ovary Syndrome ovary syndrome: a prospective parallel randomized double-blind placebo-con- trolled trial. J Clin Endocrinol Metab 2004; 89:4801-9. [Erratum, J Clin Endocrinol Metab 2005;90:3945.]
Cited by
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Self-citationFauser, B. C. J. M., Tarlatzis, B. C., Rebar, R. W., Legro, R. S., Balen, A. H., Lobo, R., Carmina, E., Chang, J., Yildiz, B. O., Laven, J. S. E., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.09.024 · Cited by 1,976
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationNorman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61345-2 · Cited by 1,360
Self-citationDiagnosis and Management of Infertility: A Review
Carson, S. A., & Kallen, A. N. (2021) · JAMA · doi:10.1001/jama.2021.4788 · Cited by 1,294
Self-citation
Metadata
- Authors
- Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Giudice, L. C., Leppert, P. C., & Myers, E. R.
- Affiliations
- Pennsylvania State University (US)
- Duke Medical Center (US)
- University of Colorado Denver (US)
- The University of Texas Southwestern Medical Center (US)
- Wayne State University (US)
- Baylor College of Medicine (US)
- University of Alabama at Birmingham (US)
- University of Pennsylvania (US)
- University of Medicine and Dentistry of New Jersey (US)
- Stanford University (US)
- University of Pittsburgh (US)
- Virginia Commonwealth University (US)
- University of California, San Francisco (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-02-08
- Volume
- 356
- Issue
- 6
- Pages
- 551-566
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2138595862
- Cited by
- 1,027
- References
- 37
- Citations by year
- 2026: 17 · 2025: 23 · 2024: 32 · 2023: 41 · 2022: 50 · 2021: 43 · 2020: 35 · 2019: 36 · 2018: 39 · 2017: 59 · 2016: 46 · 2015: 64 · 2014: 46 · 2013: 68 · 2012: 63
- FWCI
- 107.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion)
- Funders
- National Institutes of Health
- National Center for Research Resources (M01-RR00056, M01 RR10732, C06RR016499, M01RR000056, M01RR010732)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10HD033172, U10HD038999, U54-HD29834, U10HD27049, U10HD039005, U10-HD38992, U10 HD27011, U10-HD39005, U10HD027011, U10 HD38999, U10HD038998, U01HD038997, U10-HD38998, U01-HD38997, U10-HD38988, U10HD038988, U10HD027049, U10 HD33172, U10HD038992)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, infertility, clomiphene citrate, metformin, ovulation induction, live birth rate, multiple pregnancy, conception rate, early pregnancy loss, insulin sensitizers, combination therapy
- MeSH terms
- Adult, Birth Rate, Clomiphene, Drug Therapy, Combination, Female, Fertility Agents, Female, Humans, Hypoglycemic Agents, Infertility, Female, Metformin, Ovulation Induction, Patient Compliance, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Pregnancy, Multiple, Live Birth, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.